Search
for
Sort by
Research 31–60 of 1000+
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Reply to: ‘Severe diffuse non-scarring hair loss in systemic lupus erythematosus - clinical and histopathological analysis of four cases’
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- Alopecia Areata: Treatment of Today and Tomorrow
- Prioritizing dermatoses: rationally selecting guideline topics
- Update on Outcome Measures for Pediatric Systemic Lupus Erythematosus
- Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis
- Morphometric prediction of mesenchymal stromal cell-like immunosuppressive capacity of human hair follicle dermal sheath cup cells: an implication for regenerative medicine in hair loss diseases
- Acquired Progressive Kinking of Hair
- Propranolol induced alopecia
- Feline Non-Flea Induced Hypersensitivity Dermatitis
- Malassezia Folliculitis versus Truncal Acne Vulgaris (Clinical and Histopathological Study)
- Psychology of hair transplants
- Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023
- Special Issue “Recent Progress in Regenerative Therapy Using Blood-Derived Biomaterials”
- Immunotherapy with imiquimod in cervical, vaginal, and vulvar intraepithelial lesions – a review of the literature
- ATYPICAL KAWASAKI DISEASE PRESENTING AS TELOGEN EFFLUVIUM IN AN 11 YEAR OLD FEMALE
- Prognostic factors in methylprednisolone pulse therapy for alopecia areata
- Zinkkonzentration des Rattenhaares bei Zink-Depletion und -Repletion
- Developing the Breast Utility Instrument to Assess Health-related Quality of Life and Preferences in Patients with Breast Cancer
- Response of alopecia areata of the beard to oral tofacitinib
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- A molecular wound response program associated with regeneration initiation in planarians
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome